Search
Prostaglandin G2
go.drugbank.com/drugs/DB03866ExperimentalA cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. [PubChem]
Nadolol
go.drugbank.com/drugs/DB01203ApprovedInvestigationalNadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure. Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal r...
Categories: Antihypertensive Agents Indicated for HypertensionProducts: NADOLOL MK 80 MG TABLETASLAX-101
go.drugbank.com/drugs/DB05301InvestigationalLAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical.
Prolintane
go.drugbank.com/drugs/DB13438ExperimentalCategories: Psychostimulants, Agents Used for ADHD and NootropicsElobixibat
go.drugbank.com/drugs/DB12486InvestigationalElobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
Categories: Drugs for ConstipationNovaferon
go.drugbank.com/drugs/DB16483InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Calcium alginate
go.drugbank.com/drugs/DB13372ApprovedWithdrawnCategories: Compounds used in a research, industrial, or household settingOxomemazine
go.drugbank.com/drugs/DB13820InvestigationalOxomemazine is a phenothiazine derivative.
Categories: Antihistamines for Systemic UseAvdoralimab
go.drugbank.com/drugs/DB16392InvestigationalAvdoralimab is under investigation in clinical trial NCT04333914 (Prospective Study in Patients With Advanced or Metastatic Cancer and Sars-cov-2 Infection).
Neladalkib
go.drugbank.com/drugs/DB21712InvestigationalNeladalkib is under investigation in clinical trial NCT06765109 (Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC).